These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23863664)

  • 1. [A case of metastatic colon cancer effectively treated by XELOX and IRIS].
    Nishizawa T; Kinoshita S; Sakuno T; Fujiyama Y; Kikuchi M; Kaneko H; Suzuki H; Takahashi M
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):807-9. PubMed ID: 23863664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
    Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
    Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
    Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
    Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
    Cheng AL; Li J; Vaid AK; Ma BB; Teh C; Ahn JB; Bello M; Charoentum C; Chen LT; de Lima Lopes G; Ho GF; Kong HL; Lam KO; Liu TS; Park YS; Sriuranpong V; Sudoyo AW; Wang JY; Zhang J; Zhang SZ; Ciardiello F; Köhne CH; Shaw M; Kim TW
    Clin Colorectal Cancer; 2014 Sep; 13(3):145-55. PubMed ID: 25209093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete response obtained and maintained by combination of S-1 and CPT-11 in hepatic metastases of colon cancer: a case report.
    Tokunaga Y; Sasaki H; Saito T
    Anticancer Res; 2008; 28(3B):1837-40. PubMed ID: 18630468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
    Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
    Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
    Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy with oral TS-1 and low-dose CPT-11 by hepatic arterial infusion for multiple hepatic metastases from colon cancer--a case report].
    Hiraki M; Yakushiji H; Hashiguchi K; Harada S
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1055-8. PubMed ID: 16044973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of oral fluoropyrimidines in colon cancer: their role and new directions.
    Benson AB
    J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-17-21. PubMed ID: 23570133
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple hepatic metastases from colon cancer successfully treated with irinotecan and S-1 plus panitumumab as second-line therapy-a case report].
    Nakatake R; Yamamichi K; Saito T; Ueda A; Tanaka H; Motohiro T; Kwon AH
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2002-4. PubMed ID: 24393993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.
    Ducreux M; Bennouna J; Hebbar M; Ychou M; Lledo G; Conroy T; Adenis A; Faroux R; Rebischung C; Bergougnoux L; Kockler L; Douillard JY;
    Int J Cancer; 2011 Feb; 128(3):682-90. PubMed ID: 20473862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of combined chemotherapy with 5-week cycles of S-1 and CPT-11 plus bevacizumab in patients with metastatic colon cancer.
    Mizushima T; Ide Y; Murata K; Ohashi I; Yasumasa K; Fukunaga M; Takemoto H; Tamagawa H; Hasegawa J; Hata T; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Oncology; 2013; 85(6):317-22. PubMed ID: 24247419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.
    Bennouna J; Borg C; Delord JP; Husseini F; Trillet-Lenoir V; Faroux R; François E; Ychou M; Goldwasser F; Bouché O; Senellart H; Kraemer S; Douillard JY
    Clin Colorectal Cancer; 2012 Mar; 11(1):38-44. PubMed ID: 21803002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
    J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple hepatic metastases of colon cancer responding to combined therapy with TS-1 and CPT-11--a case report].
    Mouri T; Ogawa M; Mitsuyama Y; Yamagata T; Kosuge M; Ushigome T; Eto K; Watanabe M; Anazawa S; Yanaga K
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1171-3. PubMed ID: 16912543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
    Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
    Tomoda M; Kawahara H; Watanabe K; Enomoto H; Akiba T; Yanaga K
    Anticancer Res; 2014 Jan; 34(1):191-4. PubMed ID: 24403461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of non-curatively resected colon cancer with liver and lymph node metastases treated by TS-1/CPT-11 combination therapy].
    Matsutani T; Egami K; Sasajima K; Suzuki S; Maruyama H; Miyamoto M; Yokoyama T; Tajiri T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1337-40. PubMed ID: 16969037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX].
    Miyahira T; Teruya N; Matsuura F; Murayama S; Aka H; Teruya J; Hanashiro N; Nishihara M; Okushima N; Toda Y; Kiyuna M
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):331-4. PubMed ID: 20210032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completely Responsive Multiple Liver Recurrence of Colon Cancer Treated Using Chemotherapy with Oral S-1 and Oxaliplatin Plus Bevacizumab : A Case Report.
    Kabashima A; Kimura K; Sanefuji K; Maekawa S
    Fukuoka Igaku Zasshi; 2017 Jan; 108(1):8-13. PubMed ID: 29226661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.